US Representative reveals up to $30K Bitcoin exposure
Key Takeaways
- US Representative Marjorie Taylor Greene reported up to $30,000 in spot Bitcoin ETF investments.
- The information comes from a periodic transaction report.
US Representative Marjorie Taylor Greene disclosed Bitcoin exposure between $2,000 and $30,000 through purchases of the iShares Bitcoin Trust ETF, according to a recent transaction report.
Greene has filed multiple stock trades incorporating Bitcoin ETF purchases, highlighting a pattern of congressional engagement with crypto assets.
In addition to her IBIT investment, Greene reported several traditional equity purchases this month across the tech, energy, and biotech sectors, including positions in Adobe, Amazon, and Tesla.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Arm's Low-Power Architectures Overcome AI Energy Constraints, Fuel 34% Growth in Revenue
- Arm Holdings reported $1.14B Q3 revenue, 34% YoY growth surpassing forecasts, driven by AI/data center demand. - Royalty revenue rose 21% to $620M while licensing revenue jumped 56% to $515M, reflecting strong IP adoption. - Strategic shift to develop full-chip solutions via Compute Sub Systems aims to compete with Nvidia/Amazon in AI hardware. - Parent company SoftBank explored Arm-Marvell merger to strengthen AI infrastructure, highlighting industry consolidation trends. - 20 "buy" ratings and $155 pri
Fed Faces a Choice: Boost Growth or Curb Mounting Debt?
- U.S. household debt hit $18.59 trillion in Q3 2025, driven by rising credit card, student loan, and home equity debt with delinquency rates at multi-year highs. - The Fed initiated rate cuts amid slowing job growth but faces a dilemma: easing economic strain risks inflating a consumer debt bubble while tightening worsens defaults. - Retailers, banks, and auto lenders face fallout as discretionary spending declines and loan defaults rise, while essential goods and debt collectors see increased demand. - P
Antitrust Battle Ignites as Pfizer Obstructs Novo's $9 Billion Metsera Acquisition
- Novo Nordisk's $9B Metsera acquisition faces Pfizer lawsuits alleging antitrust violations and breach of contract under U.S. antitrust laws. - Pfizer claims the deal delays GLP-1 competition and binds Metsera to restrictive covenants, while Novo dismisses allegations as "baseless" and confident in antitrust compliance. - Novo cuts $8B annual costs, launches Wegovy pill, and partners with Costco/Walmart to counter 9% market share loss amid U.S. pricing pressures and patent expirations. - The obesity drug
Discord’s Family Center has been updated, allowing parents to review their children's weekly spending
Trending news
MoreCrypto prices
More
